Back to Results
First PageMeta Content
ALS Association / Amyotrophic lateral sclerosis / Medical diagnosis / Medicare / Health insurance / Motor neurone disease / Health / Medicine / Rare diseases


2nd Opinion FAQs An interview with Rup Tandan, M.D., F.R.C.P., Professor, Vice Chairman and Medical Director of The ALS Association Certified CenterSM of Excellence at the University of Vermont, Burlington Is a second op
Add to Reading List

Document Date: 2014-06-25 12:20:49


Open Document

File Size: 247,12 KB

Share Result on Facebook

City

Washington / D.C. / /

Company

Los Angeles Times / /

Continent

Europe / /

Country

United States / /

Currency

USD / /

/

Facility

University of Vermont / /

IndustryTerm

health insurance policy / health insurance / insurance decisions / /

MedicalCondition

disease / neuromuscular diseases / ALS / another disease / /

NaturalFeature

Sinai / /

Organization

Department of Corporations / ALS Association / University of Vermont / American Academy of Neurology / The ALS Association / FDA / Medicare / /

Person

Beth Karlan / Rup Tandan / Peter Clarke / /

/

Position

current physician / sub specialist / physician / Professor / Vice Chairman and Medical Director / consultant / consulting physician / neurologist / professor of preventative medicine / /

Product

Rilutek / /

ProvinceOrState

Vermont / /

PublishedMedium

Los Angeles Times / /

Region

Latin America / /

Technology

X-ray / MRI / /

URL

www.alsa.org / http /

SocialTag